Marcie A. Goldstein

Davis Polk advised the underwriters in connection with the $150 million initial public offering of 10,000,000 American Depositary Shares of BioNTech SE. In addition, the underwriters have…

Davis Polk advised the underwriters in connection with the $439 million SEC-registered offering of common stock of Grocery Outlet Holding Corp. by certain existing stockholders of Grocery…

Davis Polk advised the underwriters in connection with the $97.75 million initial public offering of 6,516,667 shares of common stock of Aprea Therapeutics, Inc., which includes 850,000…

Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 2,303,030 shares of its common stock. The common stock is listed on the…

Davis Polk advised the underwriters in connection with the $100.3 million initial public offering of 7,187,500 shares of common stock of Oportun Financial Corporation, of which 4,873,356…

Davis Polk advised the underwriters in connection with the $648 million initial public offering by Datadog, Inc. of 24,000,000 shares of its Class A common stock. The Class A common stock…

Davis Polk advised the joint book-running managers in connection with the $162.4 million SEC-registered follow-on offering of 2,680,089 shares of Class A common stock of Hamilton Lane…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC-registered offering of common stock by iRhythm Technologies, Inc…

Davis Polk advised the underwriters in connection with a $202.5 million public offering of common stock by Turning Point Therapeutics, Inc. Turning Point Therapeutics’ common stock is…

Davis Polk advised the sole bookrunner in connection with the SEC-registered offering of 2,329,000 shares of Class A common stock of Appian Corporation by Appian and certain existing…